/Boston%20Scientific%20Corp_%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
With a market cap of $155.7 billion, Boston Scientific Corporation (BSX) is a global medical device company operating through three segments: Cardiovascular, Rhythm and Neuro, and MedSurg. It offers technologies such as drug-eluting stents, implantable cardiac devices, and systems for gastrointestinal, urological, and neurological treatments.
Companies valued at $10 billion or more are generally considered "large-cap" stocks, and Boston Scientific fits this criterion perfectly. Boston Scientific has pursued both organic innovation and strategic acquisitions to build a comprehensive portfolio addressing complex diseases, including coronary artery disease, chronic pain, and cancer.